Cargando…

Angiotensin-receptor blockade in acute stroke

Detalles Bibliográficos
Autor principal:	Rajendran, Srijithesh P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141487/ https://www.ncbi.nlm.nih.gov/pubmed/21808487 http://dx.doi.org/10.4103/0972-2327.82825

Ejemplares similares

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Hypothesis and “Metahypothesis”
por: Srijithesh, P. R.
Publicado: (2012)

A Rare Case of Anti-N-Methyl-D-Aspartate Receptor Encephalitis in an Infant Presenting with Regression and Movement Disorder
por: Shivaram, Sumanth, et al.
Publicado: (2023)

Clinicians Heuristic Impression of the Presentations of Restless Legs Syndrome: A Survey among Medical Graduate Trainees in an Academic Hospital in India
por: Raja, Pritam, et al.
Publicado: (2022)

The effect of angiotensin type 1 receptor blockade on adhesion molecules in patients with IgA nephropathy
por: Xydakis, Dimitris, et al.
Publicado: (2008)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients
por: Vura, Naga Venkata Rama Krishna, et al.
Publicado: (2021)

Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab
por: Tani, Takashi, et al.
Publicado: (2022)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
por: Liu, Xiao, et al.
Publicado: (2020)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016)

Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: Blower, P, et al.
Publicado: (2002)

Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
por: Mateti, Uday Venkat, et al.
Publicado: (2014)

Treating Triple Thrombus-Pulmonary, Cardiac, and Cerebral: A Case Management with Calculated Conscience
por: Taallapalli, Ashok V. R., et al.
Publicado: (2021)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Injury, failure or success? Renin–angiotensin system inhibition in acute kidney injury
por: Ellam, Tim, et al.
Publicado: (2011)

Reply: Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: de Wit, R, et al.
Publicado: (2002)

Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)
por: Ekiz, Timur, et al.
Publicado: (2020)

RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
por: KIRKBY, N S, et al.
Publicado: (2011)

Influence of trial design, heterogeneity and regulatory environment on the results of clinical trials: An appraisal in the context of recent trials on acute stroke intervention
por: Srijithesh, P. R., et al.
Publicado: (2014)

Homogeneity and the outcome of clinical trials: An appraisal of the outcome of recent clinical trials on endovascular intervention in acute ischemic stroke
por: Husain, Shakir, et al.
Publicado: (2016)

Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse
por: Yan, YiWu, et al.
Publicado: (2015)

Management of acute ischemic stroke
por: Sharma, Vishal, et al.
Publicado: (2010)

Hyperkalemia from preoperative non-steroidal anti-inflammatory drugs and angiotensin II receptor blockers in patients with nephropathy
por: Song, Ho Kyung, et al.
Publicado: (2011)

The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
por: McLachlan, Craig Steven
Publicado: (2020)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Ultrasound-guided regional blockade – Is it always safe?
por: Kumar, Kamal, et al.
Publicado: (2011)

Treating High Blood Pressure Following Acute Stroke
por: Keir, S L, et al.
Publicado: (1996)

Acute Stroke with Concomitant Acute Myocardial Infarction: Will You Thrombolyse?
por: Maciel, Rita, et al.
Publicado: (2015)

Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases
por: Motamed, Mohammad Reza, et al.
Publicado: (2015)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Transnasal Approach to Sphenopalatine Ganglion Blockade: An Alternate Technique
por: Pai, Renuka, et al.
Publicado: (2015)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations
por: Wild, Philipp S., et al.
Publicado: (2020)

Uric Acid for Acute Stroke: Fantasy or Reality?
por: Hou, Wenshang, et al.
Publicado: (2015)

In Response Treating High Blood Pressure Following Acute Stroke
por: Bath, P M W, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_e6nn5atpglgj8l263hubaj7r65